---
title: AudioCure
date: 2014-09-16T07:34:30Z
modified: 2026-08-13T11:35:10Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/audiocure/"
type: portfolio
status: publish
excerpt: ""
wpid: 1321
language:
  - English
post_translations:
  - pll_54365d6fe992f
branchen22:
  - Hearing loss
sectors:
  - Pharmaceuticals
focus_areas:
  - Hearing Loss
timestamp: 2026-08-13T11:35:10Z
tags:
  - English
  - pll_54365d6fe992f
  - Hearing loss
  - Pharmaceuticals
  - Hearing Loss
---

## Beschreibungstext

AudioCure Pharma is an innovative clinical-stage pharmaceutical company focused on developing treatments for audiological and neurological disorders with a high unmet medical need.

Our small molecules have shown Proof-of-Principle in preclinical models for a range of otic disorders including hearing loss, tinnitus and electrode insertion trauma as well as Parkinson’s Disease. The safety and tolerability of AudioCure’s lead compound AC102 has been demonstrated in a first-in-human clinical trial. Currently, a Proof-of-Concept, Phase 2 clinical trial evaluating AC102’s efficacy in patients with Sudden Sensorineural Hearing Loss is underway across Europe.

Join us to make a meaningful impact on the lives of those affected by these disorders and turn incurable hearing loss into a treatable event.

## Unternehmenswebsite

> [Home](https://www.audiocure.com/)

## Adresse

Schlegelstr. 9
10115 Berlin

## Kontakt

Array

Array